Retreat

product on market Capsule Centurion Labz Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 40% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains ingredients like Fenugreek and D-Aspartic Acid, which are studied for their roles in supporting hormonal balance and libido. However, overall evidence coverage for this specific profile is very limited. Most components have moderate to low clinical support for enhancing athletic performance or testosterone levels.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Retreat
Open Full PDF View on NIH DSLD →
Details

Label Data

3 Capsule(s)
Serving Size
60
Servings
Other Combinations
Product Type
40%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

1500 mg
Market median: 2000.0mg (63 products)
350 mg
Market median: 500.0mg (193 products) 7 studies — no high-quality reviews
160 mg
Market median: 320.0mg (426 products) 26 studies (A:0, B:5)
Androst 3,5-Dien-7,17-Dione
75 mg
Market median: 200.0mg (3 products) 11 studies (A:1, B:3)

Other Ingredients

Gelatin Magnesium Stearate Silicon Dioxide FD&C Blue #1 FD&C Green #3 FD&C Red #3 FD&C Red #40 FD&C Yellow #6
Claims

Label Claims — Verification

Unverified No Claim
Info

Product Information

Formulation Notes

Post cycle therapy

Metadata

Product Details

DSLD Entry Date2020-04-23
Product TypeOther Combinations
FormCapsule
DSLD ID218369
Data Updated2026-04-11
Research

Research Evidence

9
Research Sources
37
Avg Quality
5
Rct
4
Other
C The Effects of Six-Gram D-Aspartic Acid Supplementation on the Testosterone, Cortisol, and Hematological Responses of Male Boxers Subjected to 11 Days of Nocturnal Exposure to Normobaric Hypoxia
Rct Nutrients 2023 PubMed DOI
C Using an experimental medicine model to understand the antidepressant potential of the N-Methyl-D-aspartic acid (NMDA) receptor antagonist memantine
Rct Journal of psychopharmacology (Oxford, England) 2012 PubMed DOI
C The effects of d-aspartic acid supplementation in resistance-trained men over a three month training period: A randomised controlled trial
Rct PloS one 2017 PubMed DOI
C Short-Term d-Aspartic Acid Supplementation Does Not Affect Serum Biomarkers Associated With the Hypothalamic-Pituitary-Gonadal Axis in Male Climbers
Rct International journal of sport nutrition and exercise metabolism 2019 PubMed DOI
C Combined melatonin and adrenocorticotropic hormone treatment attenuates N-methyl-d-aspartate-induced infantile spasms in a rat model by regulating activation of the HPA axis
Other Neuroscience letters 2021 PubMed DOI
D A placebo-controlled randomized crossover trial of the N-methyl-D-aspartic acid receptor antagonist, memantine, in patients with chronic phantom limb pain
Rct Anesthesia and analgesia 2004 PubMed DOI
D The efficacy of adrenocorticotropic hormone in a girl with anti-N-methyl-D-aspartate receptor encephalitis
Other Brain & development 2018 PubMed DOI
D The role and molecular mechanism of D-aspartic acid in the release and synthesis of LH and testosterone in humans and rats
Other Reproductive biology and endocrinology : RB&E 2009 PubMed DOI
F Blockage of N-methyl-D-aspartate receptors decreases testosterone levels and enhances postnatal neuronal apoptosis in the preoptic area of male rats
Other Neuroendocrinology 2000 PubMed
View all evidence for D Aspartic Acid →
Compare

Similar Products

View all D Aspartic Acid products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.